CNS Pharmaceuticals Ownership | Who Owns CNS Pharmaceuticals?


OverviewForecastFinancialsChart

CNS Pharmaceuticals Ownership Summary


CNS Pharmaceuticals is owned by 3.20% institutional investors, and 96.80% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.45% of its assets in CNS Pharmaceuticals shares.

CNSP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCNS Pharmaceuticals3.20%-96.80%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202216-5.88%1,282,3897.15%335.84%7-22.22%1-50.00%
Jun 30, 2022176.25%1,196,819-30.11%215.35%9-10.00%2-50.00%
Mar 31, 202216-15.79%1,712,43048.30%422.98%1011.11%433.33%
Dec 31, 20211911.76%1,154,69221.85%436.75%9-3-
Sep 30, 202117-5.56%947,605-28.57%312.69%9-350.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index6.73K0.45%-43.00
Fidelity Series Total Market Index758.000.05%-1.00
Spartan Extended Market Index Pool E145.000.01%42.00
Spartan Extended Market Index Pool F145.000.00%42.00
Vanguard Institutional Extnd Mkt Idx Tr23.000.00%-
NT Ext Eq Mkt Indx Fd DC Lending Tier 52.000.00%1.00
Northern Trust Extended Eq Market Idx9.00--
NT Ext Equity Mkt Idx Fd - L9.00--
State St US Extended Mkt Indx NL Cl C12.00--
SSgA U.S. Total Market Index Strategy5.00-1.00

Insider Transactions Trends


DateBuySell
2023 Q32-
2023 Q24-
2023 Q1-13
2022 Q4-4
2022 Q2--

CNSP Ownership FAQ


Who Owns CNS Pharmaceuticals?

CNS Pharmaceuticals shareholders are primarily institutional investors at 3.20%, followed by 0% insiders and 0% retail investors. The average institutional ownership in CNS Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which CNS Pharmaceuticals falls below.

Does Blackrock own CNS Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of CNS Pharmaceuticals.

Who is the top mutual fund holder of CNS Pharmaceuticals shares?

Fidelity Extended Market Index is the top mutual fund holder of CNS Pharmaceuticals shares, with 0.45% of its total shares outstanding invested in 6.73K CNS Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools